22 July 2021 | News
Accredify and Breathonix will be integrating their existing products to provide a quick, reliable, and affordable on-site solution
image credit- Breathonix
Singapore-based startups Accredify and Breathonix have announced their collaboration to supply an on-site COVID-19 rapid-breath test system that issues digital verifiable COVID-19 test results compliant with countries’ international travel and domestic health requirements in less than one minute.
Accredify and Breathonix will be integrating their existing products to provide a quick, reliable, and affordable on-site solution to test an individual’s COVID-19 health status with a single breath sample.
Breathonix’s proprietary rapid breath test system, the BreFenceTM Go COVID-19 Breath Test System, will collect and analyse a patient’s breath sample through a one-way disposable MouthShield. Accredify will then issue the verifiable digital COVID-19 breathalyzer test result to the patient on location.
The rapid breath test will provide a portable and efficient COVID health screening procedure to facilitate the reopening of physical offices, schools, and events.
With Accredify, BreFenceTM Go’s digital breath test results will adhere to a country’s required COVID-19 test result schema.
As a result, Breathonix’s breathalyzer test results will be internationally recognised and can be used for verification purposes by relevant authorities for international and domestic travel.
Integration is currently underway with Breathonix’s BreFenceTM Go systems in Singapore, Malaysia, and Vietnam.
This partnership will go beyond COVID-19 as Breathonix develops breath test for other critical diseases such as early detection of lung cancer.